SVB Securities analyst Roanna Ruiz initiated coverage of Corcept Therapeutics with a Market Perform rating and $25 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CORT:
- Largest borrow rate increases among liquid names
- Corcept Therapeutics Announces Final Results of Tender Offer
- Corcept initiated with Overweight, $27 target at Piper Sandler
- Corcept Therapeutics initiated with an Overweight at Piper Sandler
- Corcept Therapeutics announces preliminary results of tender offer
